CAMBRIDGE, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Transkaryotic
Therapies, Inc. (Nasdaq: TKTX) today announced that the company will be
participating at the BIO CEO & Investor Conference 2004 being held at The
Waldorf-Astoria in New York, February 23-25, 2004.
Michael J. Astrue, President and Chief Executive Officer of TKT will be
presenting an overview of the company's business, including a discussion of
its Fabry disease and Hunter syndrome programs at 11:30 a.m. Eastern Time on
Tuesday, February 24, 2004. The live audio webcast of this presentation will
be available at http://www.tktx.com on TKT's Investor Information website under
Events. A replay will be available until March 9, 2004.
In addition, TKT's Vice President of Global Regulatory Affairs and
Strategic Planning, Neil Kirby, Ph.D., is scheduled to participate on the
panel entitled, "Orphan Drugs: Small Markets, Great Need, Greater
Opportunity," on Wednesday, February 25, 2004 at 9:30 a.m. Eastern Time at the
conference.
About TKT
Transkaryotic Therapies, Inc. is a biopharmaceutical company committed to
developing treatments for rare diseases caused by protein deficiencies with a
core focus on lysosomal storage diseases. The company markets one product,
Replagal(TM), an enzyme replacement therapy for Fabry disease in Europe and
other countries and is developing treatments for Hunter syndrome and Gaucher
disease. TKT's research pipeline focuses on rare diseases where a significant
unmet medical need exists. TKT was founded in 1988 and is headquartered in
Cambridge, Massachusetts, with additional operations in Europe, Canada and
Latin America. Additional information about TKT is available on the company's
website at http://www.tktx.com.
Replagal(TM) is a trademark of Transkaryotic Therapies, Inc.
Contact:
Daniella M. Lutz
Corporate Communications Specialist
(617) 349-0205
SOURCE Transkaryotic Therapies, Inc.
 back to top
Related links:
http://www.tktx.com
Photo Notes:
NewsCom:
http://www.newscom.com/cgi-bin/prnh/19990913/TKTLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 212-782-2840
Company News On-Call:
http://www.prnewswire.com/comp/120657.html
CONTACT:
Daniella M. Lutz of Corporate Communications
Specialist, +1-617-349-0205
|
